Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
- Conditions
- Non-healing Wound
- Interventions
- Other: Platelet Rich Plasma
- Registration Number
- NCT05766982
- Lead Sponsor
- St Elizabeth Healthcare
- Brief Summary
This prospective, randomized pilot study compares the use of a xenograft with PRP to a xenograft alone for chronic, nonhealing wounds.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patient is over the age of 18 years;
- The targeted wound is deemed a chronic, nonhealing wound after six weeks of treatment; - - Patient of Dr. Eldridge, Dr. Glenn, or Dr. Worley;
- Target wound size must be between 2 cm x 2 cm x 0.1 cm deep and 10 cm x 10 cm x 5 cm deep;
- Surgical candidate for standard of care Kerecis® xenograft surgery.
- Patient with hemoglobin values less than 6.9 g/dL drawn at least 30 days prior to the Kerecis® xenograft surgery;
- Patient with a known allergy or other sensitivity to fish material;
- Patient is currently undergoing chemotherapy or radiation therapy;
- The targeted wound is of autoimmune origin; and Non-English-speaking patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Xenograft and PRP Platelet Rich Plasma The Kerecis® xenograft (Kerecis® Omega3 MariGen) will be applied with the application of PRP.
- Primary Outcome Measures
Name Time Method Time to wound being deemed healed or 6 months 6 months Assessed by time, surface area of wound, wound volume and relative surface size
- Secondary Outcome Measures
Name Time Method Wound quality of life 6 months The Wound-QoL-14 questionnaire on quality of life with chronic wounds will be used to assess changes in score prior to initial application of xenograft or xenograft/PRP to time of wound healing or 6 months, whichever comes first.
Trial Locations
- Locations (1)
St. Elizabeth Healthcare Edgewood
🇺🇸Edgewood, Kentucky, United States